Pharma Foods International Co., Ltd. completed the acquisition of the Bioscience Business of Integrale Co Ltd. for ¥140 million.
December 11, 2022
Share
Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire the Bioscience Business of Integrale Co Ltd. on February 21, 2022.
Pharma Foods International Co., Ltd. (TSE:2929) completed the acquisition of the Bioscience Business of Integrale Co Ltd. for ¥140 million on April 01, 2022
Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in mail order business and functional materials business. The Company operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The Company is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
PHARMA FOODS INTERNATIONAL CO., LTD. 
